Local pharmaceutical manufacturer targets global market with first shipment
Health & Science
By
David Njaaga
| Sep 22, 2024
A local pharmaceutical manufacturer is set to enhance Kenya's global presence through new exports.
SQUARE Pharmaceuticals marked a milestone with its first shipment from the Athi River plant on Friday.
The flag-off ceremony included officials from SQUARE Pharmaceuticals Kenya and Export Processing Zones Authority (EPZA) Director Dr. Iruki Kailemia.
The shipment consisted of 5,500 boxes of Angilock tablets, a medication for high blood pressure that combines two ingredients to help control blood pressure levels. Somalia will be the initial destination.
"This achievement reflects our dedication to providing high-quality healthcare solutions," Kailemia said, noting plans to supply other African and European countries from the plant.
READ MORE
Kenya blockchain industry urges faster stablecoin adoption amid new digital asset rules
Activist files petition to block fuel price hike, seeks conservatory orders
Government launches construction of 114 solar mini grids in 14 counties
Kenya's cybersecurity skills gap persists despite training efforts
Ruto's budget limbo deepens as IMF digs in on bailout conditions
German 'chemical town' fears impact of industrial decline
AI boom raises pressure for clean energy transition
How to pick the right insurance cover for your car
Push for cryptocurrency regulation gathers pace
How high-stakes home ownership dreams are shattered by city cartels
The firm has operated in Kenya since 2004, with its manufacturing facility opening in 2023.
Kailemia said the export will boost confidence in Kenyan-made pharmaceuticals among local healthcare professionals.
'This export demonstrates that local pharmaceuticals can meet international standards," he added.
The company employs 250 local workers and plans to increase the number to 1,000 as operations grow, with plans for a line of liquid medications and injections.